Building a CAT Clinic - real-world systems approaches to prevention and treatment

References

1. • Heit J.A.
   • Spencer F.A.
   • White R.H.
   The epidemiology of venous thromboembolism.
   J. Thromb. Thrombolysis. 2016; 41: 3-14
   View in Article

   • Google Scholar
2. • Heit J.A.
   • Silverstein M.D.
   • Mohr D.N.
   • Petterson T.M.
   • O'Fallon W.M.
   • Melton 3rd., L.J.
   Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.
   Arch. Intern. Med. 2000; 160: 809-815
   View in Article

   • Google Scholar
3. • Khorana A.A.
   • Francis C.W.
   • Culakova E.
   • Kuderer N.M.
   • Lyman G.H.
   Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.
   J. Thromb. Haemost. 2007; 5: 632-634
   View in Article

   • Google Scholar
4. • Khorana A.A.
   • Dalal M.R.
   • Lin J.
   • Connolly G.C.
   Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States.
   Clinicoecon Outcomes Res. 2013; 5: 101-108
   View in Article

   • Google Scholar
5. • Fernandez M.M.
   • Hogue S.
   • Preblick R.
   • Kwong W.J.
   Review of the cost of venous thromboembolism.
   ClinicoEconomics and outcomes research : CEOR. 2015; 7: 451-462
   View in Article

   • Google Scholar
6. • Rabinovich E.
   • Bartholomew J.R.
   • Wilks M.L.
   • Tripp B.L.
   • McCrae K.R.
   • Khorana A.A.
   Centralizing care of cancer-associated thromboembolism: the Cleveland Clinic experience.
   Thromb. Res. 2016; 147: 102-103
   View in Article

   • Google Scholar

7. TEN CATE-HOEK AJ, TOLL DB, BÜLLER HR, HOES AW, MOONS KGM, OUDEGA R, et al. Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual. J. Thromb. Haemost. 2009;7(12):2042–9.

   View in Article

   • Google Scholar
8. • Wiener R.S.
   • Gould M.K.
   • Arenberg D.A.
   • Au D.H.
   • Fennig K.
   • Lamb C.R.
   • et al.
   An official American Thoracic Society/American College of Chest Physicians Policy Statement: implementation of low-dose computed tomography lung Cancer screening programs in clinical practice.
   Am. J. Respir. Crit. Care Med. 2015; 192: 881-891
   View in Article

   • Google Scholar
9. • Raja A.S.
   • Greenberg J.O.
   • Qaseem A.
   • Denberg T.D.
   • Fitterman N.
   • Schuur J.D.
   Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the clinical guidelines Committee of the American College of physicians.
   Ann. Intern. Med. 2015; 163: 701-711
   View in Article

   • Google Scholar

10. Qdaisat A, Yeung S-cJ, Variyam DE, Badugu P, Ghaly F, Rice TW, et al. Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians Guideline. Journal of the American College of Radiology. 2020;17(1, Part A):22–30.

    View in Article

    • Google Scholar
11. • Aujesky D.
    • Roy P.M.
    • Verschuren F.
    • Righini M.
    • Osterwalder J.
    • Egloff M.
    • et al.
    Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.
    Lancet (London, England). 2011; 378: 41-48
    View in Article

    • Google Scholar
12. • Beam D.M.
    • Kahler Z.P.
    • Kline J.A.
    Immediate discharge and home treatment with rivaroxaban of low-risk venous thromboembolism diagnosed in two U.S. emergency departments: a one-year preplanned analysis.
    Acad. Emerg. Med. 2015; 22: 788-795
    View in Article

    • Google Scholar
13. • Donzé J.
    • Le Gal G.
    • Fine M.J.
    • Roy P.M.
    • Sanchez O.
    • Verschuren F.
    • et al.
    Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism.
    Thromb. Haemost. 2008; 100: 943-948
    View in Article

    • Google Scholar
14. • Jiménez D.
    • Aujesky D.
    • Moores L.
    • Gómez V.
    • Lobo J.L.
    • Uresandi F.
    • et al.
    Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism.
    Arch. Intern. Med. 2010; 170: 1383-1389
    View in Article

    • Google Scholar
15. • Kline J.A.
    • Roy P.M.
    • Than M.P.
    • Hernandez J.
    • Courtney D.M.
    • Jones A.E.
    • et al.
    Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: the POMPE-C tool.
    Thromb. Res. 2012; 129: e194-e199
    View in Article

    • Google Scholar
16. • Khorana A.A.
    • Kuderer N.M.
    • Culakova E.
    • Lyman G.H.
    • Francis C.W.
    Development and validation of a predictive model for chemotherapy-associated thrombosis.
    Blood. 2008; 111: 4902-4907
    View in Article

    • Google Scholar

17. Lyman GH, Bohlke K, Falanga A. Venous thromboembolism prophylaxis and treatment in patients with Cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Oncology Practice. 2015;11(3):e442-e4.

    View in Article

    • Google Scholar
18. • Kunapareddy G.
    • Switzer B.
    • Jain P.
    • Conces M.
    • Chen Y.-W.
    • Patel B.
    • et al.
    Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting.
    Research and Practice in Thrombosis and Haemostasis. 2019; 3: 226-233
    View in Article

    • Google Scholar
19. • Poudel S.K.
    • Park D.Y.
    • Jia X.
    • Wilks M.
    • Pinkava V.
    • O'Brien M.
    • et al.
    Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: the Cleveland Clinic experience.
    J. Thromb. Haemost. 2020; 18: 651-659
    View in Article

    • Google Scholar
20. • Angelini D.
    • Attia D.
    • Wei W.
    • Wilks M.
    • Tripp B.
    • D'Andrea C.
    • et al.
    Bleeding outcomes of gastrointestinal Cancer patients treated with direct Oral anticoagulants vs. low molecular weight heparin.
    Blood. 2020; 136: 27
    View in Article

    • Google Scholar
21. • Attia D.
    • Jia X.
    • Wilks M.
    • Tripp B.
    • D'Andrea C.
    • McCrae K.
    • et al.
    Risk of recurrent venous thromboembolism and bleeding in patients with Cancer associated thrombosis.
    Blood. 2020; 136: 18
    View in Article

    • Google Scholar
22. • Poudel S.K.
    • Reddy C.A.
    • Park D.Y.
    • Wilks M.L.
    • Pinkava V.
    • O'Brien M.
    • et al.
    Clinical outcomes of Cancer-associated thrombosis beyond 6 months of anticoagulation.
    Blood. 2019; 134: 3458
    View in Article

    • Google Scholar
23. • Soff G.A.
    • Mones J.
    • Wilkins C.
    • Devlin S.
    • Haegler-Laube E.
    • Wills J.
    • et al.
    Rivaroxaban treatment of cancer-associated venous thromboembolism: memorial Sloan Kettering Cancer center institutional experience.
    Res Pract Thromb Haemost. 2019; 3: 349-356
    View in Article

    • Google Scholar
24. • Bott-Kitslaar D.M.
    • Saadiq R.A.
    • McBane R.D.
    • Loprinzi C.L.
    • Ashrani A.A.
    • Ransone T.R.
    • et al.
    Efficacy and safety of rivaroxaban in patients with venous thromboembolism and active malignancy: a single-center registry.
    Am. J. Med. 2016; 129: 615-619
    View in Article

    • Google Scholar
25. • Wysokinski W.E.
    • Houghton D.E.
    • Casanegra A.I.
    • Vlazny D.T.
    • Bott-Kitslaar D.M.
    • Froehling D.A.
    • et al.
    Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism.
    Am. J. Hematol. 2019; 94: 1185-1192
    View in Article

    • Google Scholar
26. • Laube E.S.
    • Mantha S.
    • Samedy P.
    • Wills J.
    • Harnicar S.
    • Soff G.A.
    Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban.
    Am. J. Hematol. 2017; 92: E9-E10
    View in Article

    • Google Scholar
27. • Carrier M.
    • Abou-Nassar K.
    • Mallick R.
    • Tagalakis V.
    • Shivakumar S.
    • Schattner A.
    • et al.
    Apixaban to prevent venous thromboembolism in patients with Cancer.
    N. Engl. J. Med. 2019; 380: 711-719
    View in Article

    • Google Scholar
28. • Khorana A.A.
    • Soff G.A.
    • Kakkar A.K.
    • Vadhan-Raj S.
    • Riess H.
    • Wun T.
    • et al.
    Rivaroxaban for Thromboprophylaxis in high-risk ambulatory patients with Cancer.
    N. Engl. J. Med. 2019; 380: 720-728
    View in Article

    • Google Scholar
29. • Bosch F.T.M.
    • Mulder F.I.
    • Kamphuisen P.W.
    • Middeldorp S.
    • Bossuyt P.M.
    • Büller H.R.
    • et al.
    Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.
    Blood advances. 2020; 4: 5215-5225
    View in Article

    • Google Scholar
30. • Wang T.F.
    • Zwicker J.I.
    • Ay C.
    • Pabinger I.
    • Falanga A.
    • Antic D.
    • et al.
    The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH.
    J. Thromb. Haemost. 2019; 17: 1772-1778
    View in Article

    • Google Scholar
31. • Key N.S.
    • Khorana A.A.
    • Kuderer N.M.
    • Bohlke K.
    • Lee A.Y.Y.
    • Arcelus J.I.
    • et al.
    Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO clinical practice guideline update.
    J. Clin. Oncol. 2020; 38: 496-520
    View in Article

    • Google Scholar

32. Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. The Lancet Oncology. 2019;20(10):e566-e81.

    View in Article

    • Google Scholar

33. Holmes CE, Ades S, Gilchrist S, Douce D, Libby K, Rogala B, et al. Successful model for guideline implementation to prevent Cancer-associated thrombosis: venous thromboembolism prevention in the ambulatory Cancer clinic. JCO Oncology Practice. 2020;16(9):e868-e74.

    View in Article

    • Google Scholar
34. • Verso M.
    • Agnelli G.
    • Barni S.
    • Gasparini G.
    • LaBianca R.
    A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.
    Intern. Emerg. Med. 2012; 7: 291-292
    View in Article

    • Google Scholar
35. • Mulder F.I.
    • Horváth-Puhó E.
    • van Es N.
    • van Laarhoven H.W.M.
    • Pedersen L.
    • Moik F.
    • et al.
    Venous thromboembolism in cancer patients: a population-based cohort study.
    Blood. 2021; 137: 1959-1969
    View in Article

    • Google Scholar
36. • Roopkumar J.
    • Swaidani S.
    • Kim A.S.
    • Thapa B.
    • Gervaso L.
    • Hobbs B.P.
    • et al.
    Increased incidence of venous thromboembolism with Cancer immunotherapy.
    Med (N Y). 2021; 2: 423-434
    View in Article

    • Google Scholar